WASHINGTON (AP) — President Joe Biden examined damaging for COVID-19 on Saturday however will proceed to isolate on the White House till a second damaging take a look at, his physician mentioned.
Dr. Kevin O’Connor wrote in his latest daily update that the president, “in an abundance of caution,” will abide by the “strict isolation measures” in place since his “rebound” infection was detected July 30, pending a follow-up damaging outcome.
Biden, 79, got here down with the virus a second time three days after he had emerged from isolation from his initial bout with COVID-19, reported on July 21. There have been uncommon rebound instances documented amongst a small minority of these, who like Biden, have been prescribed the anti-viral medication Paxlovid, which has been proved to cut back the chance of significant sickness and loss of life from the virus amongst these at highest danger.
O’Connor wrote that Biden “continues to feel very well.”
Biden’s journey has been on maintain as he awaited a damaging take a look at. He plans to go to Kentucky on Monday to view harm from catastrophic flooding and meet with households.
Biden was “doing great,” White House press secretary Karine Jean-Pierre mentioned Saturday when requested about his well being throughout her look in Las Vegas at a joint convention of the National Association of Black Journalists and the National Association of Hispanic Journalists. She mentioned that when she speaks to the president, he tells her to “tell folks I’ve been working eight-plus hours a day.”
During his first go-around with the virus, Biden’s major signs have been a runny nostril, fatigue and a unfastened cough, his physician mentioned on the time. During his rebound case, O’Connor mentioned solely Biden’s cough returned and had “almost completely resolved” by Friday.
Regulators are nonetheless learning the prevalence and virulence of rebound instances, however the Centers for Disease Control and Prevention in May warned medical doctors that it has been reported to happen inside two days to eight days after initially testing damaging for the virus.
“Limited information currently available from case reports suggests that persons treated with Paxlovid who experience COVID-19 rebound have had mild illness; there are no reports of severe disease,” the company mentioned on the time.
